Ouch!
Users of the prescription cholesterol medicine Zetia and Vytorin received some troubling news from the makers of the drug on January 14: Although the pills they’re taking lower their cholesterol, there is no evidence that they reduce the risk of heart attacks and strokes, and may, in fact, be putting them at risk. In 2004, WorstPills.org - a project of Public Citizen's Health Research Group - warned subscribers not to take these drugs until more was known about them.
For a limited time, WorstPills.org is providing you with information about Vytorin at no charge.
Full statement: Drug companies, FDA lagged in warning public about Zetia, Vytorin
Our article warning consumers not to take Zetia (Ezetimibe) and Vytorin (Ezetimibe with Simvastatin)
Summaries of all of our work on high cholesterol, including information available to subscribers only
We have been advocating for drug safety for over 35 years, and in order to ensure our independence, we accept no corporate or government funding and take no advertising. Profiles of over 500 other drugs and 13 dietary supplements are available to subscribers. Other benefits of subscription include e-alerts warning you of breaking drug news and new drug articles each month.
Learn more
Users of the prescription cholesterol medicine Zetia and Vytorin received some troubling news from the makers of the drug on January 14: Although the pills they’re taking lower their cholesterol, there is no evidence that they reduce the risk of heart attacks and strokes, and may, in fact, be putting them at risk. In 2004, WorstPills.org - a project of Public Citizen's Health Research Group - warned subscribers not to take these drugs until more was known about them.
For a limited time, WorstPills.org is providing you with information about Vytorin at no charge.
Full statement: Drug companies, FDA lagged in warning public about Zetia, Vytorin
Our article warning consumers not to take Zetia (Ezetimibe) and Vytorin (Ezetimibe with Simvastatin)
Summaries of all of our work on high cholesterol, including information available to subscribers only
We have been advocating for drug safety for over 35 years, and in order to ensure our independence, we accept no corporate or government funding and take no advertising. Profiles of over 500 other drugs and 13 dietary supplements are available to subscribers. Other benefits of subscription include e-alerts warning you of breaking drug news and new drug articles each month.
Learn more
No comments:
Post a Comment